BE839893A - PREPARATION OF VACCINES BASED ON RNA NUCLEIC ACIDS ASSOCIATED WITH POLYSACCHARIDES EXTRACTED FROM MICROBIAL GERMS. - Google Patents

PREPARATION OF VACCINES BASED ON RNA NUCLEIC ACIDS ASSOCIATED WITH POLYSACCHARIDES EXTRACTED FROM MICROBIAL GERMS.

Info

Publication number
BE839893A
BE839893A BE165450A BE165450A BE839893A BE 839893 A BE839893 A BE 839893A BE 165450 A BE165450 A BE 165450A BE 165450 A BE165450 A BE 165450A BE 839893 A BE839893 A BE 839893A
Authority
BE
Belgium
Prior art keywords
preparation
nucleic acids
vaccines based
rna nucleic
acids associated
Prior art date
Application number
BE165450A
Other languages
French (fr)
Inventor
L Dussourd D Hinterland
G Normier
A M Pinel
H Serre
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE839893A publication Critical patent/BE839893A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0266—Klebsiella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0283—Shigella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
BE165450A 1975-04-02 1976-03-22 PREPARATION OF VACCINES BASED ON RNA NUCLEIC ACIDS ASSOCIATED WITH POLYSACCHARIDES EXTRACTED FROM MICROBIAL GERMS. BE839893A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7510252A FR2305990A1 (en) 1975-04-02 1975-04-02 PREPARATION OF VACCINES BASED ON RNA NUCLEIC ACIDS ASSOCIATED WITH POLYSACCHARIDES EXTRACTED FROM MICROBIAL GERMS

Publications (1)

Publication Number Publication Date
BE839893A true BE839893A (en) 1976-09-22

Family

ID=9153417

Family Applications (1)

Application Number Title Priority Date Filing Date
BE165450A BE839893A (en) 1975-04-02 1976-03-22 PREPARATION OF VACCINES BASED ON RNA NUCLEIC ACIDS ASSOCIATED WITH POLYSACCHARIDES EXTRACTED FROM MICROBIAL GERMS.

Country Status (6)

Country Link
JP (1) JPS51121511A (en)
BE (1) BE839893A (en)
DE (1) DE2613943C3 (en)
ES (1) ES446637A1 (en)
FR (1) FR2305990A1 (en)
GB (1) GB1543962A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4389396A (en) 1979-12-21 1983-06-21 Pierre Fabre, S.A. Immunostimulating preparations based on ribosomal RNA's and a process for the preparation of the RNA's
US4397838A (en) 1978-12-19 1983-08-09 Pierre Fabre S.A. Preparations of purified bacterial membranal proteoglycans

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2253499B1 (en) * 1973-12-10 1977-11-04 Fabre Sa Pierre
FR2475900A1 (en) * 1980-02-20 1981-08-21 Fabre Sa Pierre VACCINE COMPLEX CONTAINING A SPECIFIC ANTIGEN AND VACCINE CONTAINING SAME
FR2596064B1 (en) * 1986-03-18 1990-02-02 Pf Medicament INDUSTRIAL PROCESSES FOR THE MANUFACTURE OF RIBOSOMAL VACCINES AND RIBOSOMAL VACCINES OBTAINED
AR055311A1 (en) 2006-02-17 2007-08-15 H P B S A SOLID PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PROSTATE BENIGN HYPERPLASIA, PROCEDURE FOR THEIR ELABORATION AND TREATMENT METHOD

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4397838A (en) 1978-12-19 1983-08-09 Pierre Fabre S.A. Preparations of purified bacterial membranal proteoglycans
US4389396A (en) 1979-12-21 1983-06-21 Pierre Fabre, S.A. Immunostimulating preparations based on ribosomal RNA's and a process for the preparation of the RNA's

Also Published As

Publication number Publication date
DE2613943B2 (en) 1979-07-05
FR2305990A1 (en) 1976-10-29
ES446637A1 (en) 1977-06-01
DE2613943A1 (en) 1976-10-14
GB1543962A (en) 1979-04-11
FR2305990B1 (en) 1980-01-25
JPS51121511A (en) 1976-10-23
DE2613943C3 (en) 1980-03-06

Similar Documents

Publication Publication Date Title
BE857014R (en) PREPARATION OF VACCINES BASED ON RNA NUCLEIC ACIDS ASSOCIATED WITH POLYSACCHARIDES EXTRACTED FROM MICROBIAL GERMS.
BE858992A (en) VACCINE PREPARATION PROCESS
OA04704A (en) Process for the preparation of new vaccines.
NL7609213A (en) THERAPEUTIC PULLER.
NL7411565A (en) 6,11-DYHYDRODIBENZ (B, E) OXEPIN ACETIC ACIDS AND THEIR DERIVATIVES.
BE841811A (en) HEPATITIS B VACCINE
NL7804660A (en) IMPROVED VACCINES.
RO75730A (en) PROCESS FOR THE PREPARATION OF 1,2-BENZISOTIAZOL-3-ONE
BE839893A (en) PREPARATION OF VACCINES BASED ON RNA NUCLEIC ACIDS ASSOCIATED WITH POLYSACCHARIDES EXTRACTED FROM MICROBIAL GERMS.
BE822817A (en) PREPARATION OF VACCINES BASED ON ANTIGENIC RIBOSOMAL FRACTIONS.
NO810853L (en) MAGNETIC CONTROLLED PHARMACEUTICAL INFUSION SYSTEM.
FR2433540A1 (en) NOVEL CHLORAMBUCIL DERIVATIVES, CONJUGATES OF CHLORAMBUCIL AND OESTRADIOL, THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC APPLICATION
AU7490974A (en) Tetanus vaccine
BE858356A (en) 7-ACYLAMINO-8-OXO-3-OXA-1-AZABICYCLO- (4.2.0) OCTANE-2-CARBOXYLIC ACID, THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC APPLICATION
CA1004454A (en) Earth's magnetic field sensor
BE822736A (en) INFLUENZA VACCINES
FR2308634A1 (en) PROCESS FOR PREPARING CARBOXY-ALKYL-PHOSPHONIC ACIDS AND CARBOXY-ALKYL-PHOSPHINIC ACIDS
FR2313926A1 (en) SUBSTITUTED 4-PHENYL-IMIDAZOLINES, THEIR ADDITIONAL SALTS WITH ACIDS AND METHODS FOR THEIR PREPARATION
CA1014467A (en) Meningococcal vaccine
FR3026M (en) Narcotic drug based on 3-methoxy-4-n-ethyloxy-n-ethylcarbaminomethoxyphenylacetic acid n-propyl ester.
BE800132A (en) VACCINE AGAINST DOG DISEASE AND HEPATITIS
FR2301268A1 (en) POULTRY MAREK'S DISEASE VACCINE AND ITS PREPARATION
IT1028215B (en) ASSEMBLY SYSTEM FOR COMPONABLE FURNITURE MEANS TO IMPLEMENT IT AND OBTAINED FURNITURE
Bauerle Biological productivity of snakes of the Pawnee Site, 1970-1971
BE804836A (en) NEW N- (HETEROARYLMETHYL) -DESOXY-NORMORPHINES AND -NORCODEINES, THEIR ADDITIONAL SALTS WITH ACIDS, THEIR PREPARATION METHODS AND THEIR APPLICATION AS MEDICINAL PRODUCTS

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: PF MEDICAMENT S.A.

Effective date: 19960322